Are we expecting a decision on Iluvien by end of DEC 2011?
A decision on Iluvien is supposed to be out by the end of December 2011. "The Stockfather (www.thestockfather.com) reports that Alimera Sciences, Inc. (NasdaqGM: Alim) believes that it is quite possible that Iluvien could be approved for sale in Europe.
Europe is far more lenient than America is, when it comes to approving drugs and therapies for illness.
On Monday, shares of Alimera Sciences Inc. (ALIM) gained over 27%, Tuesday however, (ALIM) gave back much of Monday's gains.
Look for a strong rebound today, and look for (ALIM) to continue to run into next week.
A decision on Iluvien is supposed to be out by the end of December 2011."